← Back to headlines
Goldman Sachs Updates Stock Price Targets for Figma and Biogen
Goldman Sachs has announced updated stock price targets for both Figma and Biogen. The financial institution revised Figma's target through 2026 and established a new target for Biogen, influenced by its outlook on Alzheimer's research.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
